VoxWell
Diagnosis Using Voice Sampling
Company Overview
Snapshot
Founded in January 2025 by Efrat Kaul, VoxWell operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
VoxWell is a Health Tech & Life Sciences company that leverages advanced AI and vocal biomarkers to transform short, natural speech samples into objective, privacy-preserving signals for depression and anxiety risk. The company aims to provide a missing vital sign for mental health by analyzing subtle, non-linguistic patterns in natural speech to flag elevated risk for depression and anxiety in under a minute. Designed for health systems, digital clinics, and employers, VoxWell's platform enables proactive outreach, smarter triage, and measurable impact on outcomes and cost within the Digital Medical Diagnostics sector.
Company Intelligence Q&A
- When was VoxWell founded?
- VoxWell was founded in January 2025.
- Who is the founder of VoxWell?
- Efrat Kaul is the Co-Founder and CEO of VoxWell.
- What is VoxWell's primary focus?
- VoxWell focuses on leveraging advanced AI and vocal biomarkers to identify depression and anxiety risk from speech samples, aiming to provide a new vital sign for mental health.
- What markets does VoxWell serve?
- VoxWell designs its platform for health systems, digital clinics, and employers to enable proactive outreach and smarter triage for mental health.
- What stage is VoxWell currently in?
- VoxWell is currently in the Pre-Funding stage and its product is in the R&D phase.